Literature DB >> 19214804

The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Cheryl L Gatto1, Kendal Broadie.   

Abstract

The control of new protein synthesis provides a means to locally regulate the availability of synaptic components necessary for dynamic neuronal processes. The fragile X mental retardation protein (FMRP), an RNA-binding translational regulator, is a key player mediating appropriate synaptic protein synthesis in response to neuronal activity levels. Loss of FMRP causes fragile X syndrome (FraX), the most commonly inherited form of mental retardation and autism spectrum disorders. FraX-associated translational dysregulation causes wide-ranging neurological deficits including severe impairments of biological rhythms, learning processes, and memory consolidation. Dysfunction in cytoskeletal regulation and synaptic scaffolding disrupts neuronal architecture and functional synaptic connectivity. The understanding of this devastating disease and the implementation of meaningful treatment strategies require a thorough exploration of the temporal and spatial requirements for FMRP in establishing and maintaining neural circuit function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214804      PMCID: PMC3848790          DOI: 10.1007/s12035-009-8057-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  243 in total

1.  Four different subunits are essential for expressing the synaptic glutamate receptor at neuromuscular junctions of Drosophila.

Authors:  Gang Qin; Tobias Schwarz; Robert J Kittel; Andreas Schmid; Tobias M Rasse; Dennis Kappei; Evgeni Ponimaskin; Manfred Heckmann; Stephan J Sigrist
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

2.  Mildly impaired water maze performance in male Fmr1 knockout mice.

Authors:  R D'Hooge; G Nagels; F Franck; C E Bakker; E Reyniers; K Storm; R F Kooy; B A Oostra; P J Willems; P P De Deyn
Journal:  Neuroscience       Date:  1997-01       Impact factor: 3.590

3.  Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse.

Authors:  Yann S Mineur; Frans Sluyter; Sanne de Wit; Ben A Oostra; Wim E Crusio
Journal:  Hippocampus       Date:  2002       Impact factor: 3.899

4.  Fmrp is required for the establishment of the startle response during the critical period of auditory development.

Authors:  Seong-Wook Yun; Jimcy Platholi; Maria Sol Flaherty; Weimin Fu; Andreas H Kottmann; Miklos Toth
Journal:  Brain Res       Date:  2006-08-02       Impact factor: 3.252

5.  Epilepsy and EEG findings in males with fragile X syndrome.

Authors:  S A Musumeci; R J Hagerman; R Ferri; P Bosco; B Dalla Bernardina; C A Tassinari; G B De Sarro; M Elia
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

6.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.

Authors:  Elena D Nosyreva; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2006-02-01       Impact factor: 2.714

7.  Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Authors:  Edouard W Khandjian; Marc-Etienne Huot; Sandra Tremblay; Laetitia Davidovic; Rachid Mazroui; Barbara Bardoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

8.  Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice.

Authors:  Lujian Liao; Sung Kyu Park; Tao Xu; Peter Vanderklish; John R Yates
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

9.  Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome.

Authors:  Scott S Hall; Amy A Lightbody; Allan L Reiss
Journal:  Am J Ment Retard       Date:  2008-01

10.  Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1.

Authors:  Sean M Gallagher; Christine A Daly; Mark F Bear; Kimberly M Huber
Journal:  J Neurosci       Date:  2004-05-19       Impact factor: 6.167

View more
  22 in total

1.  hnRNP Q regulates Cdc42-mediated neuronal morphogenesis.

Authors:  Hung-Hsi Chen; Hsin-I Yu; Wen-Cheng Chiang; Yu-De Lin; Ben-Chang Shia; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2012-04-09       Impact factor: 4.272

2.  The nonsense-mediated decay pathway maintains synapse architecture and synaptic vesicle cycle efficacy.

Authors:  A Ashleigh Long; Cecon T Mahapatra; Elvin A Woodruff; Jeff Rohrbough; Hung-Tat Leung; Shikoh Shino; Lingling An; Rebecca W Doerge; Mark M Metzstein; William L Pak; Kendal Broadie
Journal:  J Cell Sci       Date:  2010-09-07       Impact factor: 5.285

3.  Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.

Authors:  R Lane Coffee; Charles R Tessier; Elvin A Woodruff; Kendal Broadie
Journal:  Dis Model Mech       Date:  2010-05-04       Impact factor: 5.758

Review 4.  Defects in translational regulation contributing to human cognitive and behavioral disease.

Authors:  J C Darnell
Journal:  Curr Opin Genet Dev       Date:  2011-07-19       Impact factor: 5.578

5.  In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation.

Authors:  R Lane Coffee; Ashley J Williamson; Christopher M Adkins; Marisa C Gray; Terry L Page; Kendal Broadie
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

6.  Neuron class-specific requirements for Fragile X Mental Retardation Protein in critical period development of calcium signaling in learning and memory circuitry.

Authors:  Caleb A Doll; Kendal Broadie
Journal:  Neurobiol Dis       Date:  2016-02-03       Impact factor: 5.996

7.  Short- and long-term memory are modulated by multiple isoforms of the fragile X mental retardation protein.

Authors:  Paromita Banerjee; Brian P Schoenfeld; Aaron J Bell; Catherine H Choi; Michael P Bradley; Paul Hinchey; Maria Kollaros; Jae H Park; Sean M J McBride; Thomas C Dockendorff
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

8.  Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.

Authors:  Aimee V Franklin; Margaret K King; Valle Palomo; Ana Martinez; Lori L McMahon; Richard S Jope
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

Review 9.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

10.  Temporal requirements of the fragile x mental retardation protein in modulating circadian clock circuit synaptic architecture.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Neural Circuits       Date:  2009-08-20       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.